FREMONT, Calif., May 09, 2017 -- Identiv, Inc. (NASDAQ:INVE) today announced the company will introduce the next generation of its uTrust Sense Temperature Tracker solution during RFID Journal LIVE! 2017. The end-to-end solution includes a low-cost, secure, portable smart sensor label that tracks and stores temperature readings, can be read locally by near field communication (NFC) readers, including mobile devices, and can be uploaded to the Internet for analysis.
The self-adhesive uTrust Sense Temperature Tracker datalogger solution is ideal for monitoring and tracking virtually any temperature-sensitive product for cold chain applications, smart packaging, medical products and pharmaceutical logistics, and other fragile goods. The precise temperature accuracy of the tag makes it ideal for use with perishable goods, including fresh fish, caviar, wine, blood, vaccines, flowers, and more, protecting product and brand integrity while significantly minimizing costs.
Identiv’s innovative solution addresses the needs of businesses requiring temperature control during air, insulated van, or refrigerated container transportation. uTrust Sense Temperature Tracker is secured by a state-of-the-art cryptographic algorithm to protect the integrity of each temperature measurement and the record transmission to the cloud platform is secured to prevent unauthorized entities from altering measurements.
“Identiv’s uTrust Sense Temperature Tracker is an unrivaled solution addressing the growing challenges in the IoT concerning data integrity and originality,” said Stephane Ardiley, Identiv Director of Product Management. “This intelligent tracking device delivers an effective and secure end-to-end solution for tracking the temperature of any goods.”
For more information or to order Identiv’s uTrust Sense Temperature Tracker, call +1 888-809-8880 or visit identiv.com/products/rfid-nfc-inlays/sensors. A demo kit featuring two tags plus access to the Android mobile app and cloud platform for data analytics is available at smartlabeldemo.com.
About Identiv
Identiv, Inc. is a global provider of physical security and secure identification. Identiv’s products, software, systems, and services address the markets for physical and logical access control and a wide range of RFID-enabled applications. Customers in the government, enterprise, consumer, education, healthcare, and transportation sectors rely on Identiv’s access and identification solutions. Identiv's mission is to secure the connected physical world: from perimeter to desktop access, and from the world of physical things to the Internet of Everything. Identiv is a publicly traded company and its common stock is listed on the NASDAQ Capital Market in the U.S. under the symbol “INVE.” For more information, visit identiv.com.
Identiv Media Contact: [email protected]


Exxon Mobil’s XTO Energy Explores Sale of Eagle Ford Shale Assets in South Texas
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks
Nintendo Stock Jumps as Switch 2 Becomes Best-Selling Console in the U.S. in 2025
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns
Toyota Recalls 162,000 Tundra Vehicles in U.S. Over Multimedia Display Issue
CN Energy Group Inc. Stock Slides After Nasdaq Delisting Notice Over Bid Price Rule
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 



